[go: up one dir, main page]

HK1050000A - Piperidine-and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases - Google Patents

Piperidine-and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases Download PDF

Info

Publication number
HK1050000A
HK1050000A HK03102032.3A HK03102032A HK1050000A HK 1050000 A HK1050000 A HK 1050000A HK 03102032 A HK03102032 A HK 03102032A HK 1050000 A HK1050000 A HK 1050000A
Authority
HK
Hong Kong
Prior art keywords
hydroxyformamides
metalloproteinases
piperidine
inhibitors
piperazine substituted
Prior art date
Application number
HK03102032.3A
Other languages
Chinese (zh)
Inventor
Christophe Barlaam Bernard
Ian Dowell Robert
Raymond Verschoyle Finlay Maurice
John Newcombe Nicholas
Tucker Howard
Waterson David
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1050000A publication Critical patent/HK1050000A/en

Links

HK03102032.3A 2000-02-21 2001-02-15 Piperidine-and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases HK1050000A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00400467 2000-02-21

Publications (1)

Publication Number Publication Date
HK1050000A true HK1050000A (en) 2003-06-06

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002219555A1 (en) VLA-4 Inhibitors
AU2001296961A1 (en) 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU2002244638A1 (en) Fumaric acid derivatives as NF-kappaB inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2002353180A1 (en) Use of ugt inhibitors to increase bioavailability
AU2001248748A1 (en) Substituted piperazine compounds
AU6381701A (en) Bisamidino compounds as nhe-3 inhibitors
AU2001245764A1 (en) Novel compounds and compositions as protease inhibitors
IL150806A0 (en) Piperidine-and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
AU2001294824A1 (en) Piperazine based inhibitors of factor xa
AU2001296515A1 (en) Cyclic sulfonyl compounds as inhibitors of metalloproteases
AU2001238590A1 (en) Substituted piperazine compounds
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002214038A1 (en) Inhibitors of transglutaminases
AU7847901A (en) Pyrrolidine derivatives as metalloprotease inhibitors
AU2001255408A1 (en) Tetrahydro-azepinone derivatives as thrombin inhibitors
AU2001274344A1 (en) Tissue inhibitors of matrix metalloproteinases
HK1050000A (en) Piperidine-and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
AU2002255613A1 (en) Piperazine derivatives as metalloprotease inhibitors
AU2002305868A1 (en) Inhibitors of reggamma
AU2001269121A1 (en) Substituted amidoalkyl-uracils as parp inhibitors
AU2001233965A1 (en) Novel cd23 inhibitors
AU2002346812A1 (en) Use of 1-phenyl-oxazolidine-2-one compounds as protease m inhibitors